TM4SF20

Chr 2AD

transmembrane 4 L six family member 20

Also known as: PRO994, SLI5, TCCE518

The encoded protein is a four-transmembrane protein that regulates CREB3L1 activation and collagen synthesis through regulated intramembrane proteolysis, with high expression in multiple brain regions including parietal and occipital lobes, hippocampus, and cerebellum. Mutations cause specific language impairment-5 with autosomal dominant inheritance. The gene shows tolerance to loss-of-function variants (low pLI score), suggesting the pathogenic variants may work through alternative mechanisms.

Summary from RefSeq, OMIM, UniProt
Research Assistant →

Primary Disease Associations & Inheritance

{Specific language impairment 5}MIM #615432
AD
0
Active trials
0
Pubs (1 yr)
0
P/LP submissions
P/LP missense
1.63
LOEUF
LOF
Mechanism· G2P
Clinical SummaryTM4SF20
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.63LOEUF
pLI 0.000
Z-score 0.34
OE 0.86 (0.471.63)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
-0.40Z-score
OE missense 1.10 (0.951.27)
131 obs / 118.9 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE0.86 (0.471.63)
00.351.4
Missense OE1.10 (0.951.27)
00.61.4
Synonymous OE0.94
01.21.6
LoF obs/exp: 6 / 7.0Missense obs/exp: 131 / 118.9Syn Z: 0.31
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
limitedTM4SF20-related specific language impairmentLOFAD
DN
0.6357th %ile
GOF
0.6932th %ile
LOF
0.2580th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

TM4SF20 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →